EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lunaemycins, New Cyclic Hexapeptide Antibiotics from the Cave Moonmilk-Dweller Streptomyces lunaelactis MM109T

Loïc Martinet, Aymeric Naômé, Lucas C D Rezende iD, Déborah Tellatin, Bernard Pignon, Jean-Denis Docquier iD, Filomena Sannio iD, Dominique Baiwir iD, Gabriel Mazzucchelli iD, Michel Frédérich iD, Sébastien Rigali iD

International Journal of Molecular Sciences · 06.01.2023 · 24 (2) · 1114

DOI: 10.3390/ijms24021114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.01.2023. Verfasst von Loïc Martinet und 10 weiteren Autor:innen. Beteiligte Einrichtung: InBioS-Centre for Protein Engineering, Institut de Chimie B6a, University of Liège, B-4000 Liege, Belgium. Hauptthemen laut MEDLINE: Anti-Infective Agents, Streptomyces. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fund for Scientific Research, Ministry of Education, Universities and Research, Walloon Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Streptomyces lunaelactis strains have been isolated from moonmilk deposits, which are calcium carbonate speleothems used for centuries in traditional medicine for their antimicrobial properties. Genome mining revealed that these strains are a remarkable example of a Streptomyces species with huge heterogeneity regarding their content in biosynthetic gene clusters (BGCs) for specialized metabolite production. BGC 28a is one of the cryptic BGCs that is only carried by a subgroup of S. lunaelactis strains for which in silico analysis predicted the production of nonribosomal peptide antibiotics containing the non-proteogenic amino acid piperazic acid (Piz). Comparative metabolomics of culture extracts of S. lunaelactis strains either holding or not holding BGC 28a combined with MS/MS-guided peptidogenomics and 1H/13C NMR allowed us to identify the cyclic hexapeptide with the amino acid sequence (D-Phe)-(L-HO-Ile)-(D-Piz)-(L-Piz)-(D-Piz)-(L-Piz), called lunaemycin A, as the main compound synthesized by BGC 28a. Molecular networking further identified 18 additional lunaemycins, with 14 of them having their structure elucidated by HRMS/MS. Antimicrobial assays demonstrated a significant bactericidal activity of lunaemycins against Gram-positive bacteria, including multi-drug resistant clinical isolates. Our work demonstrates how an accurate in silico analysis of a cryptic BGC can highly facilitate the identification, the structural elucidation, and the bioactivity of its associated specialized metabolites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Infective AgentsStreptomycesAnti-Bacterial AgentsTandem Mass SpectrometryMultigene Family

Stichwörter der Autor:innen

Anti-MRSANRPSantibioticscave microbiologycryptic metabolitesgenome miningmolecular networkingmoonmilknatural compoundspiperazic acid

Substanzen

Anti-Bacterial AgentsAnti-Infective Agents

Autor:innen und Institutionen

  • InBioS-Centre for Protein Engineering, Institut de Chimie B6a, University of Liège, B-4000 Liege, Belgium.
  • Hedera-22, Boulevard du Rectorat 27b, B-4000 Liege, Belgium.
  • Dipartimento di Biotecnologie Mediche, University of Siena, Viale Bracci 16, 53100 Siena, Italy.
  • GIGA Proteomics Facility, University of Liege, B-4000 Liege, Belgium.
  • Mass Spectrometry Laboratory, MolSys Research Unit, University of Liege, B-4000 Liege, Belgium.
  • Laboratory of Pharmacognosy, Center of Interdisciplinary Research on Medicines (CIRM), University of Liege, B-4000 Liege, Belgium.

ORCID-Profile: Lucas C D Rezende, Jean-Denis Docquier, Filomena Sannio, Dominique Baiwir, Gabriel Mazzucchelli, Michel Frédérich, Sébastien Rigali

Förderung

  • Fund for Scientific Research
  • Ministry of Education, Universities and Research
  • Walloon Government
  • Fonds National de la Recherche Scientifique (FNRS)
  • FEDER and Wallonia
  • MIUR “Progetto Dipartimenti di Eccellenza

Zitieren

APA

Martinet, L., Naômé, A., Rezende, L. C. D., Tellatin, D., Pignon, B., Docquier, J. D., Sannio, F., Baiwir, D., Mazzucchelli, G., Frédérich, M., & Rigali, S. (2023). Lunaemycins, New Cyclic Hexapeptide Antibiotics from the Cave Moonmilk-Dweller Streptomyces lunaelactis MM109T. International Journal of Molecular Sciences, 24(2), 1114. https://doi.org/10.3390/ijms24021114

Vancouver

Martinet L, Naômé A, Rezende LCD, Tellatin D, Pignon B, Docquier JD, et al. Lunaemycins, New Cyclic Hexapeptide Antibiotics from the Cave Moonmilk-Dweller Streptomyces lunaelactis MM109T. International Journal of Molecular Sciences. 2023;24(2):1114. doi:10.3390/ijms24021114

BibTeX
@article{Martinet2023,
  author = {Martinet, Loïc and Naômé, Aymeric and Rezende, Lucas C D and Tellatin, Déborah and Pignon, Bernard and Docquier, Jean-Denis and Sannio, Filomena and Baiwir, Dominique and Mazzucchelli, Gabriel and Frédérich, Michel and Rigali, Sébastien},
  title = {Lunaemycins, New Cyclic Hexapeptide Antibiotics from the Cave Moonmilk-Dweller Streptomyces lunaelactis MM109T},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {2},
  pages = {1114},
  doi = {10.3390/ijms24021114}
}
Kostenlos starten →